Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 5000.00 | 1743.19 | 3696.00 | 6184.25 | 0.5977 | 0.5089 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 5999.00 | 6184.25 | 0.9700 | 0.9670 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 5000.00 | 1743.19 | 6443.00 | 6184.25 | 1.0418 | 1.0454 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 6417.00 | 6184.25 | 1.0376 | 1.0409 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 5000.00 | 1743.19 | 3432.00 | 6184.25 | 0.5550 | 0.4489 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 5000.00 | 1743.19 | 5184.00 | 6184.25 | 0.8383 | 0.8159 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 6097.00 | 6184.25 | 0.9859 | 0.9845 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 5000.00 | 1743.19 | 4220.00 | 6184.25 | 0.6824 | 0.6225 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6284.00 | 6184.25 | 1.0161 | 1.0176 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 6207.00 | 6184.25 | 1.0037 | 1.0040 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5445.00 | 6184.25 | 0.8805 | 0.8654 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 3881.00 | 6184.25 | 0.6276 | 0.5498 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 5000.00 | 1743.19 | 6417.00 | 6184.25 | 1.0376 | 1.0409 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6259.00 | 6184.25 | 1.0121 | 1.0132 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 5000.00 | 1743.19 | 5990.00 | 6184.25 | 0.9686 | 0.9654 |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 5000.00 | 1743.19 | 6056.00 | 6184.25 | 0.9793 | 0.9772 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6136.00 | 6184.25 | 0.9922 | 0.9914 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5832.00 | 6184.25 | 0.9430 | 0.9368 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5984.00 | 6184.25 | 0.9676 | 0.9643 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5798.00 | 6184.25 | 0.9375 | 0.9306 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 5000.00 | 1743.19 | 4795.00 | 6184.25 | 0.7754 | 0.7400 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 5167.00 | 6184.25 | 0.8355 | 0.8126 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 5538.00 | 6184.25 | 0.8955 | 0.8828 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 6110.00 | 6184.25 | 0.9880 | 0.9868 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 6184.00 | 6184.25 | 1.0000 | 1.0000 |